MedTrace Logo

Platelet Function in Resuscitated Patients-2

NCT03445546 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2023-01-26

No results posted yet for this study

Summary

Approx. 65% of resuscitated patients at the intensive care unit for internal medicine are due to myocardial infarction. Almost all patients are initially diagnosed and treated in the cath lab. Therapy usually consists of one or more stent implantations. After implantation of a coronary stent, dual platelet inhibition is necessary for 12 months. Insufficient platelet inhibition causes an pronounced increase in risk of stent thrombosis. Therefore, secured inhibition and knowledge of the individual platelet function is valuable.

Conditions

  • Acute Myocardial Infarction
  • Cardiac Arrest

Interventions

DIAGNOSTIC_TEST

diagnostic test of platelet function

Light transmittance aggregometry and VerifyNow

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Dirk von Lewinski, MD · Medical University of Graz

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-01
Primary Completion
2018-05-15
Completion
2018-05-15

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03445546 on ClinicalTrials.gov